Advances in the early detection of hepatobiliary cancers

HÇ Yıldırım, G Kavgaci, E Chalabiyev, O Dizdar - Cancers, 2023 - mdpi.com
Simple Summary Hepatocellular cancer and biliary tract cancers are associated with poor
prognosis, particularly in advanced stages. However, early diagnosis offers the potential for …

[HTML][HTML] Recent advances in the management of primary sclerosing cholangitis

DN Assis, CL Bowlus - Clinical Gastroenterology and Hepatology, 2023 - Elsevier
Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease characterized by
fibroinflammatory damage to the biliary tree, typically in the setting of inflammatory bowel …

Immunobiology of primary sclerosing cholangitis

M Cornillet, D Geanon, A Bergquist, NK Björkström - Hepatology, 2024 - journals.lww.com
Primary sclerosing cholangitis (PSC) is a chronic inflammatory progressive cholestatic liver
disease. Genetic risk factors, presence of autoantibodies, the strong clinical link with …

[HTML][HTML] Prognostic models and autoimmune liver diseases

D D'Amato, M Carbone - Best Practice & Research Clinical …, 2023 - Elsevier
Autoimmune liver diseases (AILDs) are complex diseases with unknown causes and
immune-mediated pathophysiology. In primary biliary cholangitis (PBC) and autoimmune …

[HTML][HTML] Primary Sclerosing Cholangitis-Associated Cholangiocarcinoma: From Pathogenesis to Diagnostic and Surveillance Strategies

E Catanzaro, E Gringeri, P Burra, M Gambato - Cancers, 2023 - mdpi.com
Cholangiocarcinoma (CCA) is the most common malignancy in patients with primary
sclerosing cholangitis (PSC), accounting for 2–8% of cases and being the leading cause of …

Diagnosis of functional strictures in patients with primary sclerosing cholangitis using hepatobiliary contrast-enhanced MRI: a proof-of-concept study

S Poetter-Lang, A Messner, N Bastati, KI Ringe… - European …, 2023 - Springer
Objectives PSC strictures are routinely diagnosed on T2-MRCP as dominant-(DS) or high-
grade stricture (HGS). However, high inter-observer variability limits their utility. We …

ZNF460-mediated upregulation of APCDD1L-DT promotes cholangiocarcinoma development by inhibiting the ubiquitin-mediated degradation of DVL2

X Gao, X Zou, C Guan, X Sha, S Liu, X Zhang… - Cancer Gene …, 2024 - nature.com
Cholangiocarcinoma (CCA), known for its aggressive nature, poses a formidable challenge
in the current medical landscape, particularly in targeted therapies. Against this backdrop …

[HTML][HTML] The Swedish initiative for the study of Primary sclerosing cholangitis (SUPRIM)

M Cornillet, C Villard, F Rorsman, A Molinaro… - …, 2024 - thelancet.com
Background Despite more than 50 years of research and parallel improvements in
hepatology and oncology, there is still today neither a treatment to prevent disease …

Fluorescent Chemo sensor nano-materials for Cancer bio-markers signalling: Towards development of non-invasive early detection strategies

MS Ngigi - Dyes and Pigments, 2023 - Elsevier
Although current cancer treatment technologies have advanced quickly, the patient's chance
of recovering is still poor. Early detection enhances cancer prognosis and can considerably …

Risk Assessment and Cholangiocarcinoma: Diagnostic Management and Artificial Intelligence

V Granata, R Fusco, F De Muzio, C Cutolo, F Grassi… - Biology, 2023 - mdpi.com
Simple Summary The only curative treatment for intrahepatic cholangiocarcinoma (iCCA) is
surgical resection, and an early diagnosis is the most effective way to improve survival. In …